Quality Policy

We are dedicated to providing patients with medicines that comply with international standards. We are continuously training our employees on the best practices and adopting the latest technologies and equipment to provide high-quality medicines that work on curing diseases and saving lives.

Aligned with our commitment to quality, we emphasize:

  • Continuous checking and examination of all manufactured products before being packaged and distributed.
  • Maintaining state-of-the-art laboratories equipped with the latest technologies and quality control equipment for consistent quality assurance.
  • Accelerating the development of promising therapies by evaluating safety and efficacy, utilizing adaptive clinical trial designs, and leveraging real-world evidence.
  • Our suppliers are continuously monitored to ensure adherence to the highest quality standards through rigorous assessments.
  • Commitment to the modernization of technology and pharmaceutical manufacturing techniques.
  • Continuous improvement of the performance and skills of staff through effective training programs.
  • Periodic and systematic evaluation of the company’s environmental, safety, health, and occupational quality systems to measure the effectiveness of continuous improvement.

Our commitment extends to the science and activities of pharmacovigilance, as defined by the World Health Organization (WHO): 

The science and activities relating to the detection, assessment, understanding, and prevention of adverse events or any other possible drug-related problems.

The key goals of pharmacovigilance and Quality Pharmacovigilance Practice (QPPV) at IPI are listed as:

Promote awareness among patients and the public regarding the rational use of medicines via effective communication.

Enhance patient safety and care concerning the use of medicines.

Identify and report suspected adverse events to the relevant PV center.

Our QPPV plays a crucial role in bridging regulatory authorities and IPI, ensuring effective communication and compliance.

Our QPPV takes pride in adhering to both local and international regulatory authorities' guidelines for maximum compliance.

IPI participates in a comparative assessment of potentially beneficial and adverse effects of pharmaceuticals to help optimize the nature of usage.